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Tuberculosis infection notification in Swiss medical students 
during their clinical electives 
Alexander Turk,@) Felix Angst(l) and Robert Steffen(l) 
Objective: The aim of this study was to assess the tuberculin skin test conversion incidence in Swiss medical students. 
Methods: This was a prospective cohort study of medical students at the University of Zurich, using a standardized 
tuberculin skin test before and after clinical electives. 
Results: Two hundred and sixty-two students accepted the invitation to the pre-clerkship test, and 155 (59.2%) 
subjects were retested after an average period of 2.25 years. An increase of more than 10 mm in the transverse 
diameter of the induration in the retest compared to the baseline test was observed in 12 (7.7%) students.The annual 
conversion rate was 3.4% (95% CI l&6.0%). 
Conclusions: Even in an industrialized country, the risk of tuberculosis infection-as estimated by the tuberculin skin 
test-is substantial for health care professionals. Possible explanations for the high incidence and possible bias are 
discussed. 
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INTRODUCTION 
Tuberculosis is a major concern, not only in developing 
countries but also in industrial nations, where elderly 
persons, immigrants and health care workers are at 
greatest risk.l 
The current overall notification rate of tuberculosis 
in Switzerland is low. In 1995, the annual rate was 
11.5/100 000, with a substantial difference between the 
native Swiss population (6.9/100 000) and the foreign- 
born population (30.1/100 OOO).2 In 1993, there was 
concern that the reason for a renewed increase of the 
tuberculosis incidence, especially among young native 
Swiss, was HIV infection3 since it was estimated that 
one in four tuberculosis patients were HIV positive. 
Similarly, an increase was observed in other countries, 
particularly in some areas of the USA.4 
These fears may also have led to the conclusion 
that medical employees are subject to a higher risk of 
infection than the general public. Various studies have 
shown that the tuberculin skin test (TST) conversion 
rate among medical employees is higher than among 
the rest of the population. Annual employee screening 
conversion rates in US health care facilities from 1963 
to 1991 varied between 0.01% and 11%.5-9 Schoch et al 
found 37 workers with TST conversions in a larger Swiss 
hospital among 180 health care workers who had contact 
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with sputum smear-positive patients. In 20 converters, 
the increase could be attributed to causes other than a 
recent infection with Mycobacterium tuberculosis.10 
Fagan et al examined the annual conversion rate 
in US medical schools, where an annual skin test is 
routinely conducted. I1 They sent each school a question- 
naire requesting an estimate of the yearly skin test 
conversion rate in their medical students. The mean 
estimated annual conversion rate reported by 75 schools 
was 1.8%. Medical students may be at increased risk, 
being among the first to contact patients on admission 
before diagnosis is made and before therapy is admin- 
istered. 
In Switzerland, there are guidelines for the 
prevention of occupational tuberculosis, but these 
precautions are seldom followed during the first 
examination of an undiagnosed patient. We conducted 
a prospective cohort study tracking two annual courses 
of medical students undertaking their basic practical 
training at the Medical School of the University of 
Zurich. The aim was to assess tuberculosis infection 
incidence by the conversion rate of TSTs. 
METHODS 
Sample 
Medical education in Switzerland consists of a 6-year 
degree. In their 5th year, as a practical component of 
their studies, students are required to rotate among 
different hospitals and different specialties for at least 10 
months. Before commencing this clinical component of 
the degree, the students are vaccinated against hepatitis 
B and receive a TST. The base test records of two annual 
courses (1994 and 1995) were collected. After they had 
Tuberculosis infection notification in Swiss medical students during their clinical electives I Turk et al 269 
completed their clinical year, invitations for the retest 
were sent to all candidates, and the students were also 
informed through the use of overhead transparencies in 
the lecture theaters. The students who opted not to take 
the retest were phoned at home or contacted through 
their parents. 
Tuberculin skin testing 
Testing was performed by skilled staff of the Institute 
of Social and Preventive Medicine of the University of 
Zurich, according to the guidelines of the Swiss Union 
against Tuberculosis and Lung Diseases (Schweizerische 
Vereinigung gegen Tuberkulose und Lungen- 
krankheiten, SVTL) :I2 0.1 mL containing the 2-TU 
tuberculin PPD RT23 (from Berna, Berne, Switzerland) 
was administered intradermally (Mantoux technique) 
on the volar aspect of the forearm. Members of staff were 
annually instructed in administering and reading the test 
by a senior member of the institute. They were blinded 
to the results of the first skin test of the students and to 
the history of exposure to tuberculosis. 
After an interval of 72 h, the maximal transverse 
diameter of the induration in millimeters was measured 
with a flexible plastic ruler using the ballpoint method.r3 
After an average observation period of 2.25 years, changes 
in the transverse diameter of the induration were re- 
assessed by a retest. The results were entered into each 
student’s personal vaccination document, where infor- 
mation about their vaccination with Bacille Calmette- 
Guerin (BCG) was also recorded. 
Questionnaire 
After taking the second test, every subject was re- 
quested to complete a questionnaire. Information was 
gathered about age, sex, type and duration of clinical 
clerkship, and possible contact with cases of infectious 
tuberculosis. Furthermore, there were questions regard- 
ing possible tuberculosis infection and therapy, other 
TSTs during that period, contact with tuberculosis outside 
of the clerkship, contacts with at-risk populations (HIV- 
positive people, residents in old people’s home, 
intravenous drug users) and immunodeficiency. 
Case definition and analysis 
The size of the transverse diameter of the induration 
of the TST is currently the best method to ascertain 
the probability of the occurrence of tuberculosis in- 
fection. A change from baseline examination to retest 
of more than 10 mm defined a conversion according to 
the guidelines of the Schweizerische Vereinigung gegen 
Tuberkulose und Lungenkrankheiten (SVTL) for 
preventive chemotherapy. l4 The absolute value greater 
than 10 mm at retest and previous BCG vaccination are 
relevant for other interpretation strategies.sJsJ6 Contact 
with sputum smear-positive tuberculosis was examined 
as a predictor for conversion. 
RESULTS 
Subjects 
Among 491 students enrolled in 1994 and 1995 at the 
Medical School of the University of Zurich, 262 (53.4%) 
responded to the invitation for the baseline test and 155 
presented themselves for a retest, representing 59.2% of 
all candidates who had a baseline test (Table 1). Only 
three questionnaires were not returned, and attempts 
to trace them remained unsuccessful, leaving a sample 
of 152 subjects with complete data. In the whole study 
population, 35 (23%) did a part of their clinical rotations 
in foreign countries: 14 in western Europe, one in 
eastern Europe, eight in North America, Australia 
and the Pacific region, and 12 in developing countries. 
According to the study coordinator, 25% of all the 
students enrolled in these two classes went abroad for 
l-3 months. The mean age was 27 years at the second 
testing (Table 1). All students were Caucasians and had 
lived for at least 4 years in Switzerland before the first 
testing. 
Tuberculin test results 
Figures 1 and 2 show the overall distribution of the 
results for the baseline test and for the retest for the 
subjects with complete sets of baseline tests and retests 
(n=155). The distribution of the pairwise differences 
between the baseline test and the retest per subject is 
Table 1. Number of conversions of both classes in relation to the observation time and the annual conversion rate 
Class 1994 95% Cl Class 1995 95% Q Total 95% CI 
No. of results at first testing 
No. of results at second testing 
Response rate (%) 
Mean age at second testing 
Conversions 
% conversions 
Observation time in person-years 
% conversions/year 
130 132 
73 82 
56.2 62.1 
27 years 26 years 
4 months 11 months 
5 1.6-11.7 7 
6.8 2.2-16.0 8.5 
177.26 172.08 
2.8 0.9-6.6 4.1 
2.8-14.4 
3.4-17.6 
1.6-8.4 
262 
155 
59.2 
27 years 
2 months 
12 6.2-21.0 
7.7 4.0-13.5 
349.34 
3.4 1.8-6.0 
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Figure 1. Distribution of all the results of the baseline test. Total number of subjects=155. Possible digit preferences are marked 
with an asterisk. 
50 
45 
40 
35 
3 30 
o 
% 
25 
6 20 
= 15 
10 
5 
0 
0 2 4 6 8 10 12 14 16 18 20 22 24 
Transverse diameter (mm) 
Figure 2. Distribution of all the results of the retest. Total number of subjects=l55. Possible digit preferences are marked with an 
asterisk. 
shown in Figure 3. A positive difference indicates an 
increase, and a negative difference a decrease, in the 
subject’s tuberculin reaction at retest compared to the 
baseline test. 
Among the 155 students, there were 12 cases (7.7%, 
95% CI 4.0-13.5%) who had an increase of more than 
10 mm of their TST (beyond the bold line at the cutoff 
point in Figure 3). With an overall observation time of 
349.35 person-years and an individual average obser- 
vation period of 2.25 years, 3.4% conversions per year 
(95% CI l&6.0%) were found (Table 1). Of the 12 
subjects who demonstrated a TST conversion, one did a 
part of the clinical electives in New York City, while the 
other 11 subjects did all clinical rotations in Switzerland. 
Contact with infectious tuberculosis patients and 
BCG vaccination 
Of the 155 students, 55 (35.5%) recalled having had 
contact with infectious tuberculosis patients during their 
clinical work, 62 indicated having no contact, 35 could 
not recall such exposure, and three students did not 
return the questionnaires. This results in a relative risk 
(RR) of 1.26 ((5/55)/(7/97)) for remembered contact 
with infectious tuberculosis patients, with a 95% CI 
of 0.38-4.16. Among the 12 students with conversions 
who all returned their questionnaires, five remembered 
contact, whereas three reported no contact and four 
could not remember if they had any. 
Tuberculosis infection notification in Swiss medical students during their clinical electives I Turk et al 271 
60 
50 
40 
8 
2 o 30 5 
6 
= 20 
10 
0 
48 
-18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8 10 12 14 16 18 
Difference between base test and retest (mm) 
Figure 3. Pairwise differences between tuberculin baseline test and retest of 155 medical students. The bold line indicates the cutoff 
point for conversions (>I0 mm) according to the guidelines of the SVTL. 
One hundred and thirty (83.9%) students had 
received BCG vaccination, usually during childhood. 
Eleven of the 12 people with conversions had received 
a previous BCG vaccination. In one case, the vaccination 
status was unknown. 
DISCUSSION 
Incidence of the tuberculin skin test conversion 
In our data, a conversion rate of 7.7% (95% CI 
4.0-13.5%) was observed after an average observation 
period of 2.25 years, corresponding to 3.4% conversions 
per year (95% CI 1.8-6.0%).All these test subjects with 
conversions were sent to their family physicians to 
confirm a possible tuberculosis infection-in particular 
with a chest X-ray-and to receive secondary pro- 
phylaxis with isoniazid as recommended by the 
guidelines for management of tuberculosis.i2J4 
Our annual conversion rate falls among median 
values in similar studies conducted elsewhere. The con- 
version rate can be considered as remarkably high for 
Switzerland. A study of TSTs among hospital employees 
in Switzerland showed that, among 180 workers who 
had contact with sputum smear-positive tuberculosis 
patients, 37 (20.6%) had increases compared to their 
initial tuberculin tests (at the time of employment). Of 
those 37 increases, 20 (11.1%) were retrospectively 
attributed to causes other than a recent infection 
with Mycobacterium tuberculosis.1° Over the past three 
decades, the reported annual incidence rates among 
American health care workers varied between 0.01% 
and 11.0%,9 medical students accounting for 1.8%.11 
There are four possible explanations for the com- 
paratively high conversion rate of 7.7%: 
false administration and reading technique 
boosting resulting from repeated skin testing, BCG 
vaccination or infection with environmental myco- 
bacteria 
selection bias 
true conversions. 
Administering and reading technique 
Although only well-instructed and blinded (to previous 
test and history of exposure) staff members administered 
the test, it is nevertheless possible that false readings 
could have occurred. In Figures 1 and 2, digit-preferences 
for 5 mm and 8 mm might be suspected, but no pre- 
ference for even numbers or for the numbers 10 and 15 
is observed.17 We therefore tried to maximize valid and 
reliable test results. 
Boosting resulting from repeated skin testing, 
BCG vaccination or infection with environmental 
mycobacteria 
When repeating a tuberculin skin test within less than 
1.5 years, one may trigger false-positive reactions due to 
boosting. 12,1sr9 In our sample, only two subjects were 
retested within 1.5 years of the base test, and both were 
positive. The question arises whether we have to 
consider boosting after a longer interval than 1.5 years. 
This phenomenon is more likely to occur in older 
people; for example, the rate is 20% among 50-year- 
olds.12 Therefore, in our young population, the number 
of false-positive results may be considered small. 
In our sample,, 83.9% of the 155 students had 
received a previous BCG vaccination approximately 
20 years earlier. It is very likely that, after such a long 
272 International Journal of Infectious Diseases I Volume 7, Number 4,2003 
interval, the first reaction to tuberculin wanes and that 
the second reaction could be ‘boosted’. It is therefore 
known that the extent of waning differs for different 
vaccines and ages at vaccination.20,21 It is also known 
that different BCG strains induce tuberculin reactivity 
to different degrees, which makes clear interpretation 
more difficult.22 In the recent literature, it is recom- 
mended to administer two-step initial skin testing to 
eliminate up to 80% of false-positive ‘boosted’ con- 
versions due to BCG vaccinations.23 On the other hand, 
the guidelines of the SVTL for prevention of occupa- 
tional tuberculosis24 recommend the administration of 
two-step tuberculin testing only in employees older than 
35 years; however, no one exceeded this limit in our 
sample. 
The amount of boosting due to infection by 
ubiquitous environmental mycobacteria is usually 
considered to be underestimated, particularly in warmer 
climates. In colder climates, such as in Switzerland, the 
rate of conversion due to nontuberculosis mycobacteria 
is considered to be low.25,26 
Selection bias 
Only 59.2% of the students tested pre-clerkship could 
be retested after the period of their clinical rotation, 
which is less than expected, even though several 
attempts were made to reach and motivate the students. 
The low response rate could be accounted for by the fact 
that testing was done on a voluntary basis and that 
tuberculosis is probably not perceived as an important 
health risk among young health professionals.Testing on 
a voluntary basis may increase the conversion rate, due 
to selection of subjects with increased risk. It is possible 
that students presented themselves who knew that they 
had been subjected to a higher risk of infection. Among 
our subjects, 23% spent part of their time in clinical 
rotations in foreign countries, but only 13 students (8%) 
stayed in non-Western countries. Therefore, comparing 
this figure with the total of 24% of all students in the two 
studied age classes who went abroad for a few months 
(l-3 months), there is no overrepresentation of students 
who have been abroad in the sample.Although we made 
inquiries concerning the countries and the medical 
specialties (surgery, internal medicine, etc.) in which the 
students worked, it is impossible to assess the individual 
risk of each student and the distribution of tuberculosis 
risk. However, on the basis of the above-mentioned 
figures, we think that the majority of the students were 
at low risk. 
Furthermore, there is remarkable variability in the 
predictive value of a positive tuberculin test, depending 
on the sample selection: based on TSTs of more than 500 
000 Navy recruits, 27 the positive predictive value 
for persons having had contact with tuberculosis could 
be as high as 70%, whereas, for those without contact, 
the positive predictive value was only 1O%.28 On the 
other hand, Geiseler et al have found in the USA that 
tuberculin-negative graduates from one medical school 
from 1938 to 1981, 63% of whom subsequently had 
active tuberculosis, converted their tuberculin reaction 
during medical school or clinical training.2g 
True conversions 
Finally, the most important reason for an increase in 
positive Mantoux skin tests is infection with M. 
tuberculosis. The annual conversion rate of 3.4% is 
higher than expected, and there are not only true 
conversions, although this is comparable with 1.8% 
conversions per year among medical students in the 
USA.ll However, it is undeniable that students are often 
unprotected when seeing a patient before a diagnosis is 
made and therapy is administered. 
Whether one can determine a true tuberculosis 
infection by skin testing is a question of the positive 
predictive value of the test, which depends on the pre- 
valence. Some authors report high sensitivity (94%)28 
and a positive predictive value of 88% at a prevalence 
of lo%, but a positive predictive value of only 16% at a 
prevalence of 0.28%. 3o This has led to a broad discussion 
regarding the appropriateness and practicality of the 
TST to diagnose tuberculosis infection, especially when 
there is a clinically manifest course.30m32 
CONCLUSION 
Even in an industrialized country such as Switzerland, 
the risk of tuberculosis infection may persist for certain 
risk groups, such as health care workers, if one is 
considering only tuberculin skin testing. However, the 
conclusion that a positive skin test result implies a 
true tuberculosis infection is dependent on the positive 
predictive value of the test, which is problematically low 
in populations with low disease prevalence. Because 
nearly every medical student has had a BCG vaccina- 
tion, obtaining a clear interpretation of tuberculin 
conversions is a challenge. Therefore, the conclusion 
that every converted person has true tuberculosis is 
problematic, due to the various problems of testing, 
interpretation, and manifestation, leading to difficulties 
in the guidelines and management of the disease. 
Initial two-step tuberculin skin testing is recom- 
mended,19 but it is obvious that this is insufficient to 
eliminate all false-positive (e.g. ‘boosted’) results. Based 
upon our results, we consider compulsory tuberculin 
skin testing after the clinical rotations for medical (and 
nursing) students to be desirable. Exposure to sputum 
smear-positive tuberculosis cannot lead to a valid risk 
assessment. However, there is a lack of valid and 
reliable new data on risk assessment, incidence rates and 
prevalence of tuberculosis among medical personnel. 
Given this current situation, the actual guidelines for 
preventive chemotherapy and strategies of primary 
prevention of tuberculosis need to be discussed and 
further improved. 
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